Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06541652
What this trial is testing

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Who this might be right for
HepatocholangiocarcinomaFibrolamellar CarcinomaHepatic Epithelioid Hemangioendothelioma+7 more
Federation Francophone de Cancerologie Digestive 150
Not applicableUnknownNCT05907447
What this trial is testing

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types

Who this might be right for
LymphomaExtranodal LymphomaDiffuse Large B Cell Lymphoma+6 more
Ruijin Hospital 10,000
Not applicableNot Yet RecruitingNCT07125105
What this trial is testing

Integrating Art Therapy and Adapted Physical Activity: Toward Improved Quality of Life in Patients With Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Universite du Littoral Cote d'Opale 102
Not applicableActive Not RecruitingNCT01517945
What this trial is testing

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Who this might be right for
Breast CancerRare Cancer
Memorial Sloan Kettering Cancer Center 252
Testing effectiveness (Phase 2)Looking for participantsNCT06563999
What this trial is testing

Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.

Who this might be right for
Lung Cancer Stage IIIMutation
Sun Yat-sen University 120
Not applicableLooking for participantsNCT06193850
What this trial is testing

Protocol N. 2014 - Observational Study on the Quality of Life of Outpatients

Who this might be right for
Urologic DiseasesMale InfertilitySexual Medicine
IRCCS San Raffaele 10,000
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Looking for participantsNCT01356290
What this trial is testing

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Who this might be right for
Medulloblastoma RecurrentEpendymoma RecurrentATRT Recurrent+1 more
Medical University of Vienna 232
Testing effectiveness (Phase 2)Study completedNCT03012581
What this trial is testing

Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types

Who this might be right for
Carcinoma, Renal CellHead and Neck NeoplasmSkin Neoplasms+3 more
UNICANCER 269
Not applicableLooking for participantsNCT04731857
What this trial is testing

Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes

Who this might be right for
Rare DiseasesGenetic Predisposition
University Hospital Tuebingen 12,000
Testing effectiveness (Phase 2)Ended earlyNCT03173950
What this trial is testing

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Who this might be right for
MedulloblastomaEpendymomaPineal Region Tumors+2 more
National Cancer Institute (NCI) 136
Not applicableStudy completedNCT00007046
What this trial is testing

Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone

Who this might be right for
StenosisHistiocytoma
National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04931342
What this trial is testing

A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors

Who this might be right for
Ovarian Cancer
Hoffmann-La Roche 176
Not applicableStudy completedNCT05581979
What this trial is testing

PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers

Who this might be right for
Salivary Gland TumorRare Malignant Neoplasm
National Cancer Centre, Singapore 4
Testing effectiveness (Phase 2)Study completedNCT00004311
What this trial is testing

Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome

Who this might be right for
Acanthosis NigricansPolycystic Ovary Syndrome
National Center for Research Resources (NCRR)
Early research (Phase 1)Study completedNCT04084067
What this trial is testing

Indocyanine Green (ICG) Guided Tumor Resection

Who this might be right for
Neoplastic DiseaseSolid Tumor
St. Jude Children's Research Hospital 215
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Looking for participantsNCT06119789
What this trial is testing

Precision Cancer Therapy in Rare Cancers

Who this might be right for
Rare Malignant Neoplasm
Oslo University Hospital 96
Testing effectiveness (Phase 2)WithdrawnNCT04106843
What this trial is testing

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

Who this might be right for
Locally Advanced Adrenal Gland PheochromocytomaLocally Advanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+11 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT01878617
What this trial is testing

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

Who this might be right for
Medulloblastoma
St. Jude Children's Research Hospital 660
Next Page